[Federal Register: September 5, 2003 (Volume 68, Number 172)]
[Notices]               
[Page 52776]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr05se03-67]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Manufacturing Subcommittee of the Advisory Committee for 
Pharmaceutical Science; Amendment of Notice

AGENCY:  Food and Drug Administration, HHS.

ACTION:  Notice.

-----------------------------------------------------------------------

    The Food and Drug Administration (FDA) is announcing an amendment 
to the notice of meeting of the Manufacturing Subcommittee of the 
Advisory Committee for Pharmaceutical Science. This meeting was 
announced in the Federal Register of August 14, 2003 (68 FR 48614). The 
amendment is being made to reflect a change in the date and time, 
agenda, and procedure portions of the meeting. Due to administrative 
complications, all topics previously announced will be discussed on 
September 17, 2003. There are no other changes.

FOR FURTHER INFORMATION CONTACT:  Hilda Scharen, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), 
Rockville MD 20857, 301-827-7001, or FDA Advisory Committee Information 
Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 
12539. Please call the Information Line for up-to-date information on 
this meeting.

SUPPLEMENTARY INFORMATION: In the Federal Register of August 14, 2003, 
FDA announced that a meeting of the Manufacturing Subcommittee of the 
Advisory Committee for Pharmaceutical Science would be held on 
September 17 and 18, 2003. On page 48614, in the second column, the 
agenda portion of the meeting is amended to read as follows:
    Date and Time: The meeting will be held on September 17, 2003, from 
8:30 a.m. to 5 p.m.
    Agenda: On September 17, 2003, the subcommittee will discuss the 
following topics: (1) Quality by design and how it is distinct from 
approaches that attempt to test in quality; and (2) define principles 
by which risk management is integrated into decisionmaking.
    Procedures: Oral presentations from the public will be scheduled 
between approximately 11:30 a.m. and 12:30 p.m.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: August 29, 2003.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 03-22628 Filed 9-4-03; 8:45 am]

BILLING CODE 4160-01-S